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Deletion 11q is a rare cytogenetic abnormality in the myeloid disorders, with a reported prevalence of 0.7% in de novo and secondary AML and MDS in one study. 5 While the prognostic significance of del(11q) is uncertain, a previous report on deletion 11q23 showed that 15/16 AML and 5/12 MDS patients died with a median overall survival of 14.1 months. 6 We performed molecular cytogenetics characterization of del(11q) abnormality based on archival material in AML and MDS patients diagnosed at our center. Fluorescence in situ hybridization (FISH) and comparative genomic hybridization (CGH) procedures were carried out in accordance with previously published protocols. 7 A review of patient records revealed nine cases of del(11q) detected among 819 cases (1.1%) of AML and MDS diagnosed in the past 10 years ( Table 1) . The deletion existed both as a sole abnormality (n = 6) and in association with other changes (n = 3), including t(8;21) in case 2. Conventional cytogenetic analysis showed terminal deletion in six (Figure 1a) . Based on morphological and CGH results (performed in cases 4, 6-9), the deletion involved proximal regions of chromosome band 11q23.
As the mixed lineage leukemia (MLL) gene is located at the 11q23 breakpoint, we performed interphase FISH on six cases (1-3, 7-9) in which cells in Carnoy's fixative were available, using a MLL dualcolor break-apart rearrangement probe (Vysis, Downers Grove, IL, USA). It consisted of a 350 kb centromeric fragment and a 190 kb telomeric fragment labeled with different fluorochromes. Four cases showed a predominance of a single fusion signal (Figure 1b) , consistent with preservation of one allele and deletion of the other. Case 7 showed MLL split signal in keeping with gene rearrangement (Figure 1c) , which was confirmed with Southern blot hybridization using PS/4 probe on BamHI, EcoRI and SacI digests (Figure 1d ). Review of the karyotype showed subtle elongation of chromosome 6q ( Figure 1e ). Further metaphase FISH using the relevant whole chromosome painting probes (Vysis) showed addition of chromosome 11 material to 6q27 (Figure 1g ), and was confirmed by employing respective painting probes with reversed fluorochrome label (data not shown). Unbalanced changes such as addition of chromosome 11qter material to the telomere of chromosome 6 was ruled out by the presence of intact telomeres on both chromosomes as demonstrated by FISH ( Figure 1h ) using a PNA telomere probe set (Dako, Copenhagen, Denmark). While chromosomal rearrangement in this case might have resulted in fusion between MLL and a candidate gene most likely AF6 based on breakpoint location at 6q27, unfortunately no sample was available to decipher this possibility. Finally, there was a predomi Figure 1 (a) Conventional cytogenetics and CGH characterization of deleted segment at chromosome 11q. The black line denotes deletion at cytogenetics level in nine patients, whereas the red line denotes CGH results in five patients (cases 4, 6-9). In case 7, the absence of 11q abnormality on CGH most probably represents balanced rearrangement between chromosomes 6 and 11. , showing addition of chromosome 11 material to 6q27. While the CGH result suggested balanced rearrangement, the presence of chromosome 6 material was not detected on chromosome 11q, most probably related to lack of sensitivity of chromosome painting probes to detect minute subtelomeric chromosomal material. (h) Intact telomeres on chromosomes 6 and 11 as detected by FISH using a PNA probe set for human telomeres. nance of two fusion signals in case 2, indicating the presence of two MLL alleles. Subsequent re-analysis of the karyotype showed the presence of 11q material on long arm of chromosome 15, so that del(11q) and add(15q) should be revised as t(11;15)(q21;q26) (Figure 1f) . No metaphase, however, was available in the Carnoy's fixative for confirmation by chromosome painting experiments. The presence of three of four signals in this case indicated the existence of extra MLL alleles, most probably as a result of duplication of the derivative chromosome 15 in small numbers of cells.
Our study showed that, in agreement with a prior FISH study, 8 del(11q) in myeloid malignancies uniformly involved band 11q23. It is tempting to speculate, based on our data, that monoallelic MLL deletion may play a role in initiation or progression of myeloid malignancies with del(11q) abnormality, especially in light of the hematological abnormalities displayed in MLL +/− mice 9 indicative of haploinsufficiency. More importantly, we showed that del(11q) is heterogeneous at the molecular level and may be a pointer for cryptic rearrangements involving the chromosome 11q or the MLL gene. It follows therefore that the presence of del(11q) in the myeloid malignancies necessitates further characterization by molecular cytogenetics techniques, in particular to detect cryptic MLL translocations that are of prognostic significance. We report here on the first patient with simultaneous CML and CLL evolved to myeloid blast crisis, in which the origin of the two cell lines was determined by means of molecular studies and immunophenotyping, combined to interphase hybridization techniques.
In June 1995, a 64-year-old rural dweller was diagnosed as having CML concurrent with CLL. Physical and computed tomography examination revealed only a slight splenomegaly and no lymphadenomegaly. Blood examination showed hemoglobin (Hb) of 14.6 g/dl and a white blood cell (WBC) count of 38.8 × 10 9 /l with 51% neutrophils, 3% eosinophils, 8% basophils, 10% lymphocytes, 13% smudge cells, 2% monocytes, 1% blasts, 2% promyelocytes, 9% myelocytes, 1% metamyelocytes. Platelet count was 610 × 10 9 /l. The leukocyte alkaline phosphatase score was 31 (normal value, 40-60). Bone marrow biopsy showed an increase of myelopoietic lineages, and a fair nodular infiltration of mature-appearing lymphocytes. Immune surface marker analysis of blood and bone marrow lymphocytes revealed 50% of cells to be CD5, CD19, CD23 positive, SIg (lambda) weakly positive, FMC7 negative and 34% CD5-CD19 (simultaneous staining) positive. Patient remained well under hydroxyurea (1 g/day) treatment until February 2000, when a myeloid blast crisis occurred. Thirthy percent of peripheral blasts were positive for myeloperoxidase, Sudan black B and CD13 and negative for CD10, CD19 and CD7. Bone marrow lymphocytic infiltration accounted for 35% of cells. The patient died in April 2000 without remission being obtained.
Cytogenetic studies were performed on bone marrow and peripheral blood cells, by standard G-banding technique. Interphase-FISH was performed on peripheral blood nuclei using two probes: LSI D13S25 Spectrum Orange and Rb-1 Spectrum Orange (Vysis, Downers Grove, IL, USA) for a common segment of loss of 13q in lymphoproliferative disorders. Centromeric probe for chromosome 12 (C-12) was also tested (Oncor, Gaithersburg, MD, USA). FICTION (fluorescence immunophenotype and interphase cytogenetics as a tool for investigation of neoplasm). The procedure was adapted from Weber-Matthiesen et al. 4 At diagnosis, cytospins and monoclonal antibodies anti-CD13 and anti-CD5 (Dako, Glostrup, Denmark) were used. After immunostaining, slides and probes were co-denaturated on a hot plate at 75°C for 7 min and hybridized overnight at 37°C. Probes were BCR-ABL and D13S25 (Vysis). Immunophenotype and hybridization signals were evaluated simultaneously on 100 intact cells for each antibody using an Olympus fluorescence microscope with triple band filter. To study BCR and immunoglobulin gene rearrangement, the chimeric BCR-ABL messengers, coding for p190 or p210 proteins, were detected on total RNA extracted from bone marrow and peripheral blood mononuclear cells collected at the time of diagnosis, by nested reverse transcriptase-polymerase chain reactions (RT-PCR). 5 The presence of a clonal heavy chain immunoglobulin gene rearrangement was investigated by Southern blot analysis, as described elsewhere. 6 Cytogenetic studies showed a 46,XY,t(9;22) karyotype in 88% of metaphases and a normal karyotype in the remaining 12%.
FISH investigations on 300 interphase nuclei detected the presence of a clonal deletion at 13q with 18% of nuclei showing only one signal for the D13S25 probe, whereas the Rb-1 probe gave two signals, as espected in normal cells. Trisomy 12 was excluded by C-12 probe.
FICTION studies revealed the presence of BCR-ABL fusion signal only in myeloid cells (CD13 positive) (Figure 1a) , while CD5-positive elements were normal (Figure 1c) . Moreover D13S25 probe showed only one signal in the 50% of lymphoid cells (CD5-positive) and two
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Simultaneous phenotypic and genotypic analysis. 
